1-5 of 5
Iyas Hamwi
Close
Sort by
Journal Articles

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Clinical Trials & Observations
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, Piroska Klement, Johannes Schiller, Christian Kandziora, Lothar Hambach, Michael Stadler, Christian Koenecke, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Konstantin Büttner, Bennet Heida, Sabrina Klesse, Anuhar Chaturvedi, Arnold Kloos, Gudrun Göhring, Brigitte Schlegelberger, Verena I. Gaidzik, Lars Bullinger, Walter Fiedler, Albert Heim, Iyas Hamwi, Matthias Eder, Jürgen Krauter, Richard F. Schlenk, Peter Paschka, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Michael Heuser
Journal: Blood
Blood (2018) 132 (16): 1703–1713.
https://doi.org/10.1182/blood-2018-02-829911
Published: 2018
Includes: Supplemental data
Journal Articles

Next-Generation Sequencing-Based Measurable Residual Disease (MRD) Monitoring Is Highly Predictive for Outcome after Allogeneic Stem Cell Transplantation

Felicitas Thol, MD, Alessandro Liebich, Razif Gabdoulline, PhD, Piroska Klement, Johannes Schiller, Christian Kandziora, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Sabrina Klesse, Anuhar Chaturvedi, PhD, Arnold Kloos, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Lars Bullinger, MD, Walter Fiedler, MD, Albert Heim, MD, Lothar Hambach, MD, Michael Stadler, MD PhD, Iyas Hamwi, MD, Matthias Eder, Jürgen Krauter, MD, Richard F. Schlenk, MD, Konstanze Dohner, MD, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4513.
https://doi.org/10.1182/blood.V130.Suppl_1.4513.4513
Published: 2017
Journal Articles

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Eva M Weissinger, MD, Metzger Jochen, PhD, Michael Schleuning, MD, Christoph Schmid, Diethelm Messinger, Gernot Beutel, MD, Eva-Maria Wagner, MD, Johannes Schetelig, MD, Herrad Baurmann, MD, Andreas Rank, MD, Friedrich Stolzl, MD, Kerstin Schäfer-Eckhard, MD, Karin Westphal, Wolfgang Bethge, MD, Donald w. Bunjes, MD, Daniela Heidenreich, MD, Stefan Klein, MD, Daniel Wolff, MD, Ernst Holler, MD, Hans H Kreipe, MD PhD, Danny Jonigk, Irina Türüchanow, Clara Rothmann, Julia Raad, Annika Durban, Iyas Hamwi, MD, Steve Ehrlich, MD, Patrick Schweier, Jurgen Krauter, MD, Michael Stadler, MD PhD, Arnold Ganser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 512.
https://doi.org/10.1182/blood.V130.Suppl_1.512.512
Published: 2017
Journal Articles

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

Clinical Trials & Observations
Frederik Damm, Michael Heuser, Michael Morgan, Katharina Wagner, Kerstin Görlich, Anika Großhennig, Iyas Hamwi, Felicitas Thol, Ewa Surdziel, Walter Fiedler, Michael Lübbert, Lothar Kanz, Christoph Reuter, Gerhard Heil, Ruud Delwel, Bob Löwenberg, Peter J. M. Valk, Jürgen Krauter, Arnold Ganser
Journal: Blood
Blood (2011) 117 (17): 4561–4568.
https://doi.org/10.1182/blood-2010-08-303479
Published: 2011
Includes: Supplemental data
Journal Articles

Favorable Prognostic Impact of WT1 SNP rs16754 in Cytogenetically Normal AML Independent of MN1, BAALC, and ERG Expression.

Frederik Damm, M.D., Juergen Krauter, Iyas Hamwi, Michael A. Morgan, Ph.D., Gudrun Goehring, Brigitte Schlegelberger, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2009) 114 (22): 1622.
https://doi.org/10.1182/blood.V114.22.1622.1622
Published: 2009